The D3 Study: Drug Delivery vs Drops - A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexamethasone (Primary) ; Bromfenac; Moxifloxacin; Prednisolone acetate
Indications Ocular inflammation; Ocular pain; Postoperative inflammation; Postoperative pain
Focus Adverse reactions; Therapeutic Use
Acronyms The D3 Study

Most Recent Events

09 Dec 2020 Status changed from recruiting to completed.
16 Nov 2020 Results presented in an EyePoint Pharmaceuticals media release.
16 Nov 2020 According to an EyePoint Pharmaceuticals media release, the data from this study were presented at the American Academy of Ophthalmology (AAO) 2020 Virtual Annual Meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight